Skip to main content

PVM Faculty Play Prominent Role in Purdue University’s Unique Center for Cancer Research

Dr. Knapp works with oncology team to ultrasound a dog in the Purdue University Small Animal Hospital
The Purdue University Center for Cancer Research connects more than 110 researchers from across the university to study cancer on the cellular level. The work in PCCR’s labs advances understandings of cancer prevention, detection, diagnosis, and treatment. One of those faculty members is Dr. Deborah Knapp, Distinguished Professor and Dolores L. McCall Professor of Comparative Oncology, who is performing an ultrasound on a dog. PCCR is the nation’s only National Cancer Institute basic laboratory cancer center that includes a college of veterinary medicine. (Purdue University photo/John Underwood)

As one of only seven basic laboratory cancer centers recognized by the National Cancer Institute, which is part of the National Institutes of Health, the Purdue University Center for Cancer Research (PCCR) connects more than 110 researchers from across the university, including faculty in the College of Veterinary Medicine.  As the only NCI basic laboratory cancer center that includes a college of veterinary medicine, PCCR has the unique opportunity to study canine oncology while giving dogs chances to live longer, fuller lives.

“We actually treat canine cancers,” said Dr. Timothy L. Ratliff, the Robert Wallace Miller Director of the PCCR and Distinguished Professor of Comparative Pathobiology in the College of Veterinary Medicine. “Pet owners are ecstatic that we can extend the lives of their pets, and we utilize this process to better understand cancer in people,” Dr. Ratliff said.

One of the researchers involved in the PCCR is Dr. Deborah Knapp, the Dolores L. McCall Professor of Comparative Oncology in the College of Veterinary Medicine and 2017 Purdue Research Foundation Innovator Hall of Fame inductee.  Dr. Knapp has recognized bladder cancer in dogs as the most relevant model for invasive bladder cancer in humans. By treating canine patients, Purdue’s researchers can observe therapies in clinical settings comparable to human circumstances.

The PCCR, which celebrated its 40th year as an NCI-recognized member in 2018, recently received a five-year accreditation extension as part of the competitive renewal of its NCI basic laboratory cancer center status.  The work in the PCCR’s labs advances understandings of cancer prevention, detection, diagnosis, and treatment.  Researchers study cancer on the cellular level – a form of molecular research that is the foundation of all drug discovery. “We study normal cell function in very basic systems like yeast, fruit flies, and zebrafish,” said Dr. Ratliff. “They’re simple models that help us define pathways quite rapidly and effectively.”

PCCR also advances technologies in cancer detection, imaging, and treatment thanks to the university’s roster of experts in engineering and related fields. Engineering and physics methods allow the production of tools that improve effectiveness of cancer-related drugs. Other innovations allow cancer researchers to better understand the cellular changes that happen in tumor formation. Collaborations such as these are unusual for academic institutions.  “Only MIT [Massachusetts Institute of Technology] has a similar marriage with engineering,” Dr. Ratliff said.

PCCR researchers also work diligently to move discoveries out of the lab and into public use in conjunction with the Purdue Institute for Drug Discovery. Because investigating the safety and efficacy of drugs is an expensive, time-consuming process, Dr. Ratliff co-founded Boilermaker Health Innovations, a certified nonprofit that helps fund Purdue-discovered drugs through human clinical trials. Compounds that make it through a Phase I trial can often be sold to an established pharmaceutical manufacturer or spun off into a for-profit company.

One of the center’s most recognized success stories is Endocyte Inc., a startup originating from the work of PCCR member Philip S. Low, co-founder of Boilermaker Health Innovations, Presidential Scholar in Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry. Dr. Low’s research, which focuses on providing direct-targeted treatment to diseased cells through the creation of small molecules, helped the biopharmaceutical company reach its $2.2 billion value. PCCR was instrumental in advancing a key targeting molecule by initiating a Phase 0 clinical trial that had such positive results it was a critical drug that contributed significantly to the sale of Endocyte Inc., Dr. Ratliff said.

Click here to view a complete news release about the PCCR and its ongoing research.

Writer(s): Christy McCarter, Purdue News Service, and Kevin Doerr | pvmnews@purdue.edu

Recent Stories

DVM and Veterinary Technology students gain job opportunity insights at fall PVM Career Fair

Purdue Veterinary Medicine's Fall Career Fair brought veterinary and veterinary technology students together with employers on October 30 at the Purdue Memorial Union. Students explored career opportunities, internships and externships while meeting representatives from veterinary practices and organizations.

In Memory: Dr. Mary Beth Leininger (PU DVM ’67)

Purdue Veterinary Medicine remembers Dr. Mary Beth Leininger (DVM 1967), who died November 6, 2026, at age 83. The first woman elected president of the American Veterinary Medical Association, she spent nearly three decades in private practice and held leadership positions in veterinary medicine, industry and education.

“Paws Up” for Kayla Fuqua – brought to you by the PVM Wellness Committee

Kayla Fuqua, the day-shift Emergency and Critical Care receptionist at our veterinary hospital, is this week's Paws Up honoree. A colleague recognized her for supporting clients, coworkers and veterinary students, answering questions and helping her department during busy shifts.

MMAS Symposium at Purdue provides hands-on learning about Medicine of Mammalian and Avian Species

More than 80 participants joined Purdue Veterinary Medicine's 2026 Medicine of Mammalian and Avian Species Symposium on October 31 and November 1. Organized by the Exotic Animal Club, the two-day event combined presentations on exotic animal medicine with hands-on training in parrot handling, rabbit examinations, avian clinical pathology and other specialized topics.

Costumed characters boost Halloween spirits in Lynn Hall

Halloween brought Minions, the Lorax, Super Mario Bros. characters and plenty of other costumes to Purdue Veterinary Medicine. Students, faculty and staff celebrated with costume contests, trick-or-treating and a Halloween dessert competition in Lynn Hall, the Reed ADDL and the Veterinary Hospital.